{
  "id": 200414,
  "name": "EDWARDS LIFESCIENCES, LLC",
  "slug": "edwards-lifesciences-llc",
  "state": "CA",
  "description": "Medical equipment company",
  "totalSpending": 1370000,
  "filings": 33,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 150000
    },
    {
      "year": 2019,
      "income": 120000
    },
    {
      "year": 2020,
      "income": 120000
    },
    {
      "year": 2021,
      "income": 230000
    },
    {
      "year": 2022,
      "income": 150000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 200000
    },
    {
      "year": 2025,
      "income": 200000
    }
  ],
  "firms": [
    "FARRAGUT PARTNERS LLP"
  ],
  "lobbyists": [
    "JEFFERY MORTIER",
    "JEFF MACKINNON",
    "JOSEPH VASAPOLI",
    "JODY GALE",
    "SARAH WALTER",
    "J WALSH",
    "EDWARD WHITFIELD",
    "KRISTEN O'NEILL",
    "WILLIAM KRIEGER",
    "KRISTEN BAUTZ",
    "DYLAN MOORE",
    "CONSTANTINE HINGSON"
  ],
  "issues": [
    "HCR",
    "MMM",
    null
  ],
  "sampleDescriptions": [
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. TAVR National Transcatheter Aortic Valve Replacement.",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. TAVR NCD.",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical\ninnovation. TAVR NCD.",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical\ninnovation. TAVR National Transcatheter Aortic Valve Replacement.",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting\nmedical \ninnovation. TAVR National Transcatheter Aortic Valve Replacement.",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting\nmedical \ninnovation. TAVR NCD.",
    "21st Century Cures 2.0",
    "Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 33,
  "trajectory": "growing",
  "yearsActive": 8,
  "avgAnnualSpending": 171250,
  "peakYear": 2021,
  "lobbyistCount": 12,
  "firmCount": 1,
  "issueCount": 2
}